{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:44:21Z","timestamp":1785915861413,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hpb.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:53:22Z","timestamp":1779231202000},"page":"1125-1135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-0737","authenticated-orcid":false,"given":"Salar","family":"Javanshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8709-1285","authenticated-orcid":false,"given":"Isabella","family":"Angeli-Pahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1824-5130","authenticated-orcid":false,"given":"Pavan","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3939-3569","authenticated-orcid":false,"given":"Anastasia","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9339-5273","authenticated-orcid":false,"given":"Iulia M.","family":"Smarandache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6460-8958","authenticated-orcid":false,"given":"Rishiraj","family":"Ganguli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-8584","authenticated-orcid":false,"given":"Abhishek","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1014-1656","authenticated-orcid":false,"given":"Jessica","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8258-1032","authenticated-orcid":false,"given":"Adriana","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7641-1350","authenticated-orcid":false,"given":"Gabrielle","family":"Suchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3994-8157","authenticated-orcid":false,"given":"Carl","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3172","authenticated-orcid":false,"given":"Fahreddin","family":"Palaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-6942","authenticated-orcid":false,"given":"Steven J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2070-9319","authenticated-orcid":false,"given":"Ilyas","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9704-2447","authenticated-orcid":false,"given":"Joseph R.","family":"Grajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-6850","authenticated-orcid":false,"given":"Sergio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-1816","authenticated-orcid":false,"given":"Ali","family":"Zarrinpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.05.004_bib1","doi-asserted-by":"crossref","DOI":"10.20517\/2394-5079.2021.130","article-title":"Epidemiology of cholangiocarcinoma","volume":"8","author":"Turati","year":"2022","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.hpb.2026.05.004_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2026.05.004_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hpb.2026.05.004_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.hpb.2026.05.004_bib5","article-title":"Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study","volume":"11","author":"Yu","year":"2021","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.hpb.2026.05.004_bib6","first-page":"19","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.hpb.2026.05.004_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11894-011-0178-8","article-title":"Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis","volume":"13","author":"Charbel","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.hpb.2026.05.004_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-017-0542-4","article-title":"Update on the diagnosis and treatment of cholangiocarcinoma","volume":"19","author":"Doherty","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.hpb.2026.05.004_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2026.05.004_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ajt.16906","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma","volume":"22","author":"McMillan","year":"2022","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.hpb.2026.05.004_bib11","doi-asserted-by":"crossref","first-page":"45335","DOI":"10.18632\/oncotarget.17336","article-title":"Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2026.05.004_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/hpb.12359","article-title":"Outcomes following resection of intrahepatic cholangiocarcinoma","volume":"17","author":"Tabrizian","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2026.05.004_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238392","article-title":"Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: a multi-institutional study by the Okayama Study Group of HBP surgery","volume":"15","author":"Kojima","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.05.004_bib14","series-title":"Established and emerging biomarkers for prediction, early detection, and prognostication of cholangiocarcinoma","first-page":"413","author":"Garcia-Sampedro","year":"2021"},{"key":"10.1016\/j.hpb.2026.05.004_bib15","first-page":"3555","article-title":"Diagnostic accuracy of Serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.hpb.2026.05.004_bib16","first-page":"605","article-title":"Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma","volume":"41","author":"Li","year":"2009","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.hpb.2026.05.004_bib17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.hpb.2026.05.004_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"19","author":"Bj\u00f6rnsson","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.hpb.2026.05.004_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(95)90462-X","article-title":"Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"108","author":"Ramage","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2026.05.004_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133222","article-title":"Next-Generation biomarkers for cholangiocarcinoma","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.hpb.2026.05.004_bib21","first-page":"744","article-title":"Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.hpb.2026.05.004_bib22","article-title":"Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis","volume":"34","author":"Saha","year":"2022","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2026.05.004_bib23","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4269\/ajtmh.17-0879","article-title":"Biomarkers for the diagnosis of cholangiocarcinoma: a systematic review","volume":"98","author":"Tshering","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.hpb.2026.05.004_bib24","doi-asserted-by":"crossref","first-page":"13261","DOI":"10.1038\/s41598-019-49860-0","article-title":"Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information","volume":"9","author":"Ettrich","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.hpb.2026.05.004_bib25","doi-asserted-by":"crossref","first-page":"48832","DOI":"10.18632\/oncotarget.9453","article-title":"Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2026.05.004_bib26","article-title":"The application of circulating tumour DNA (ctDNA) in the diagnosis, prognosis, and treatment monitoring of gynaecological and breast cancers","volume":"15","author":"Englisz","year":"2025","journal-title":"Diagn Basel Switz"},{"key":"10.1016\/j.hpb.2026.05.004_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2024.10.043","article-title":"et al.,Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma","volume":"82","author":"Yoo","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2026.05.004_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/XCS.0000000000000939","article-title":"Methylated ctDNA quantification: noninvasive approach to monitoring hepatocellular carcinoma burden","volume":"238","author":"Angeli-Pahim","year":"2024","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2026.05.004_bib29","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.7150\/ijbs.44024","article-title":"Q. Dong, et al., Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma","volume":"16","author":"Wu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.hpb.2026.05.004_bib30","doi-asserted-by":"crossref","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.05.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00324","article-title":"Circulating Tumor DNA profiling of advanced biliary tract cancers","author":"Mody","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.hpb.2026.05.004_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.hpb.2026.05.004_bib33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jmb.2019.10.021","article-title":"Toward a mechanistic understanding of DNA methylation readout by transcription factors","volume":"432","author":"Kribelbauer","year":"2020","journal-title":"J Mol Biol"},{"key":"10.1016\/j.hpb.2026.05.004_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","article-title":"DNA methylation profiling: an emerging paradigm for cancer diagnosis","volume":"17","author":"Papanicolau-Sengos","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.hpb.2026.05.004_bib35","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1128\/MCB.22.9.3157-3173.2002","article-title":"Molecular mechanisms of gene silencing mediated by DNA methylation","volume":"22","author":"Curradi","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.hpb.2026.05.004_bib36","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.3390\/cancers14194818","article-title":"Cell-Free DNA\u2013Based multi-cancer early detection Test in an asymptomatic screening population (NHS-Galleri): design of a pragmatic, prospective randomised controlled trial","volume":"14","author":"Neal","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.hpb.2026.05.004_bib37","doi-asserted-by":"crossref","unstructured":"Singal AG, Kurtzman KN, Thompson MJ. Leveraging multi-cancer blood tests to improve diagnostic efficiency for patients with nonspecific signs and symptoms. Future Oncol. 20:2603-2607. doi:10.1080\/14796694.2024.2388505.","DOI":"10.1080\/14796694.2024.2388505"},{"key":"10.1016\/j.hpb.2026.05.004_bib38","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1038\/s41598-025-90013-3","article-title":"Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring","volume":"15","author":"Ye","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.hpb.2026.05.004_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/gutjnl-2020-322983","article-title":"Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis","volume":"71","author":"Goeppert","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2026.05.004_bib41","series-title":"R studio","year":"2025"},{"key":"10.1016\/j.hpb.2026.05.004_bib42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-Genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hpb.2026.05.004_bib43","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.hpb.2026.05.004_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-023-10159-2","article-title":"HOXA9 transcription factor is a double-edged sword: from development to cancer progression","volume":"43","author":"Shenoy","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.hpb.2026.05.004_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-024-01389-x","article-title":"Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis","volume":"24","author":"Shenoy","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.hpb.2026.05.004_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-638","article-title":"High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer","volume":"14","author":"Laurberg","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2026.05.004_bib47","first-page":"1361","article-title":"Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach","volume":"28","author":"Cho","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.hpb.2026.05.004_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cas.14693","article-title":"FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer","volume":"112","author":"Hasegawa","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hpb.2026.05.004_bib49","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.3390\/cells11223556","article-title":"CD36-Fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages","volume":"11","author":"Zaidi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.hpb.2026.05.004_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-019-0151-7","article-title":"E-selectin fills two needs for metastasis","volume":"19","author":"Harjes","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hpb.2026.05.004_bib51","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.18632\/oncotarget.14399","article-title":"TMPRSS2-ERG fusion promotes prostate cancer metastases in bone","volume":"8","author":"Deplus","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2026.05.004_bib52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00432-024-05950-9","article-title":"HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma","volume":"150","author":"Bao","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hpb.2026.05.004_bib53","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1158\/0008-5472.CAN-16-2797","article-title":"TWIST1-WDR5-Hottip regulates Hoxa9 Chromatin to facilitate prostate cancer metastasis","volume":"77","author":"Malek","year":"2017","journal-title":"Cancer Res"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:48Z","timestamp":1785912408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26006167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1365182X26006167"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.05.004","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}